Is cbd a hallucinogen
Pro Research Analysisby 
Searched over 200M research papers
Is CBD a Hallucinogen?
Understanding Cannabidiol (CBD) and Its Effects
Cannabidiol (CBD) is a non-psychoactive compound found in the Cannabis sativa plant. Unlike tetrahydrocannabinol (THC), which is known for its psychoactive properties, CBD does not produce the "high" associated with cannabis use. This distinction is crucial when considering whether CBD can be classified as a hallucinogen.
CBD and Hallucinogenic Properties
Lack of Psychoactive Effects
CBD is widely recognized for its lack of psychoactive effects. Research indicates that CBD does not induce the hallucinogenic experiences typically associated with THC or other serotonergic hallucinogens like ayahuasca. In a study examining the interactive effects of ayahuasca and CBD, it was found that CBD did not enhance or moderate the hallucinogenic effects of ayahuasca. Instead, CBD was well-tolerated and did not produce significant psychoactive effects on its own.
Medical Use and Schizophrenia
The medical properties of CBD have been explored extensively, particularly in the context of schizophrenia. Unlike THC, which can trigger psychotic episodes, CBD has been shown to have anti-psychotic-like properties. Studies suggest that CBD can ameliorate both positive and negative symptoms of schizophrenia, making it a potential alternative treatment for the condition. This further supports the notion that CBD does not act as a hallucinogen but rather has therapeutic benefits without inducing hallucinations.
Conclusion
Based on current research, CBD cannot be classified as a hallucinogen. It lacks the psychoactive properties that characterize hallucinogenic substances and has been shown to have therapeutic effects, particularly in the treatment of schizophrenia. Therefore, CBD is considered a non-psychoactive compound with significant medical potential.
Sources and full results
Most relevant research papers on this topic